Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

奥克列珠单抗纳塔利祖玛芬戈莫德医学多发性硬化内科学复发-缓解造血干细胞移植肿瘤科免疫学移植美罗华淋巴瘤

作者

Tomáš Kalinčík,Sifat Sharmin,Izanne Roos,Mark S. Freedman,Harold Atkins,Joachim Burman,Jennifer Massey,Ian Sutton,Barbara Withers,Richard Macdonell,Andrew Grigg,Øivind Torkildsen,Lars Bø,Anne Kristine Lehmann,Eva Havrdová,Eva Krasulová,Marek Trněný,Tomáš Kozák,Anneke van der Walt,Helmut Butzkueven,Pamela McCombe,Olga Skibina,Jeannette Lechner‐Scott,Barbara Willekens,Elisabetta Cartechini,Serkan Özakbaş,Raed Alroughani,Jens Kühle,Francesco Patti,Pierre Duquette,Alessandra Lugaresi,Samia J. Khoury,Mark Slee,Recai Türkoğlu,Suzanne Hodgkinson,Nevin John,Davide Maimone,María José Sá,Vincent Van Pesch,Oliver Gerlach,Guy Laureys,Liesbeth Van Hijfte,Rana Karabudak,Daniele Spitaleri,Tünde Csépány,Riadh Gouider,Tamara Castillo‐Triviño,Bruce Taylor,Basil Sharrack,John A. Snowden,Dana Horáková,Katherine Buzzard,Murat Terzi,Alexandre Prat,Marc Girard,Pierre Grammond,Michael Barnett,Grace Stewart,Marco Onofrj,Guillermo Izquierdo,Sara Eichau,François Grand’Maison,Julie Prévost,Bart Van Wijmeersch,Maria Pia Amato,Vahid Shaygannejad,Cavit Boz,R. Fernandez Bolanos,Aysun Soysal,Cristina Ramo‐Tello,Claudio Solaro,Claudio Gobbi,José Antonio Cabrera-Gómez,E Roullet,Cees Zwanikken,Leontien Den Braber‐Moerland,Norma Deri,Maria Luisa Saladino,Edgardo Cristiano,Juan Ignacio Rojas,Cárlos Vrech,Cameron Shaw,Neil Shuey,Mike Boggild,Ik Lin Tan,Todd A. Hardy,D. Decoo,Fraser Moore,Jiwon Oh,Patrice H. Lalive,Radek Ampapa,Thor Petersen,Celia Oreja‐Guevara,Ángel Pérez Sempere,José Andrés Domínguez,Sarah Besora,Stella Hughes,Orla Gray,Nikolaos Grigoriadis,Piroska Imre,Csilla Rózsa,Krisztián Kása,Magdolna Simó,Krisztina Kovács,Attila Sas,Enikő Dobos,Cecília Rajda,Chris McGuigan,Deborah Mason,Jan Schepel,Jabir Alkhaboori,Maria Edite Rio,Simu Mihaela,Talal Al‐Harbi,Ayşe Altıntaş,Ilya Kister,Mark Marriott,Trevor J. Kilpatrick,John King,Ai‐Lan Nguyen,Chris Dwyer,Mastura Monif,Izanne Roos,Lisa Taylor,Matteo Diamanti,Clara Grazia Chisari,Simona Toscano,L Salvatore,Catherine Larochelle,Giovanna De Luca,V. Di Tommaso,D. Travaglini,Erika Pietrolongo,Maria di Ioia,D. Farina,Luca Mancinelli,Raymond Hupperts,Javier Olascoaga,Albert Saiz,Robert Zivadinov,Ralph H. B. Benedict,Freek Verheul,Marzena J. Fabis‐Pedrini,Saloua Mrabet,Justin Garber,José Luis Sánchez-Menoyo,Eduardo Agüera,Yolanda Blanco,Abdullah Al‐Asmi,Bianca Weinstock‐Guttman,Yára Dadalti Fragoso,Koen de Gans,Allan G. Kermode

出处

期刊：JAMA Neurology [American Medical Association]
日期：2023-05-15 卷期号：80 (7): 702-702 被引量：16

链接

europepmc.org europepmc.org ugent.be ugent.be ugent.be ac.uk nih.gov ac.uk handle.net unibo.it handle.net uantwerpen.be nih.govdoi.org

标识

DOI：10.1001/jamaneurol.2023.1184

摘要

Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS).

求助该文献

最长约 10秒，即可获得该文献文件

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

今日热心研友